Prothena News

Analysts Have Lowered Expectations For Prothena Corporation Plc (NASDAQ:PRTA) After Its Latest Results

Yahoo FinanceMay 12 20:05

Piper Sandler Sticks to Their Buy Rating for Prothena (PRTA)

TipRanksMay 10 20:05

Buy Rating Affirmed for Prothena Amid Strong Pipeline and Financial Health

TipRanksMay 10 13:30

Prothena Price Target Cut to $83.00/Share From $85.00 by JMP Securities

Prothena Price Target Cut to $83.00/Share From $85.00 by JMP Securities

Dow JonesMay 10 02:51

Prothena Is Maintained at Market Outperform by JMP Securities

Prothena Is Maintained at Market Outperform by JMP Securities

Dow JonesMay 10 02:51

Prothena Is Maintained at Buy by HC Wainwright & Co.

Prothena Is Maintained at Buy by HC Wainwright & Co.

Dow JonesMay 10 02:07

HC Wainwright & Co. Maintains Buy on Prothena Corp, Lowers Price Target to $84

HC Wainwright & Co. analyst Andrew Fein maintains Prothena Corp with a Buy and lowers the price target from $90 to $84.

Analyst UpgradesMay 10 01:57

Analysts Are Bullish on These Healthcare Stocks: Paragon 28 (FNA), Prothena (PRTA)

TipRanksMay 9 12:50

Prothena (PRTA) Reports Q1 Loss, Lags Revenue Estimates

Yahoo FinanceMay 9 06:10

Prothena: Q1 Earnings Snapshot

BarchartMay 9 05:14

Prothena | 10-Q: Quarterly report

Futu NewsMay 9 04:25 · Announcements

Prothena 1Q R&D Expenses $64,114 >PRTA

Prothena 1Q R&D Expenses $64,114 >PRTA

Dow JonesMay 9 04:25

Prothena Corp Q1 2024 GAAP EPS $(1.34) Misses $(1.20) Estimate, Sales $900.00K Miss $2.17M Estimate

Prothena Corp (NASDAQ:PRTA) reported quarterly losses of $(1.34) per share which missed the analyst consensus estimate of $(1.20) by 11.67 percent. The company reported quarterly sales of $900.00 tho

BenzingaMay 9 04:22

Earnings Flash (PRTA) PROTHENA CORPORATION Posts Q1 Revenue $50,000

04:13 PM EDT, 05/08/2024 (MT Newswires) -- Earnings Flash (PRTA) PROTHENA CORPORATION Posts Q1 Revenue $50,000

MT NewswiresMay 9 04:13

Prothena 1Q Loss/Shr $1.34 >PRTA

Prothena 1Q Loss/Shr $1.34 >PRTA

Dow JonesMay 9 04:05

Prothena 1Q Rev $50,000 >PRTA

Prothena 1Q Rev $50,000 >PRTA

Dow JonesMay 9 04:05

Prothena 1Q Loss $72.2M >PRTA

Prothena 1Q Loss $72.2M >PRTA

Dow JonesMay 9 04:05

Press Release: Prothena Reports First Quarter 2024 Financial Results and Business Highlights

Prothena Reports First Quarter 2024 Financial Results and Business Highlights -- Net cash used in operating and investing activities was $73.2 million in the first quarter of 2024; quarter-

Dow JonesMay 9 04:05

Press Release: Prothena to Report First Quarter 2024 Financial Results on May 8

Prothena to Report First Quarter 2024 Financial Results on May 8 DUBLIN, Ireland--(BUSINESS WIRE)--May 01, 2024-- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company

Dow JonesMay 2 05:24

Prothena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia & Lymphoma

Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced the publication

BusinesswireApr 16 04:05